Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
752.48M | 746.61M | 658.58M | 582.17M | 518.40M | 432.32M | Gross Profit |
233.69M | 254.01M | 204.21M | 169.23M | 126.74M | 89.16M | EBIT |
33.20M | 43.71M | 37.57M | 30.46M | 28.85M | 25.90M | EBITDA |
58.47M | 70.78M | 59.27M | 56.06M | 37.59M | 38.79M | Net Income Common Stockholders |
4.68M | 11.18M | 18.89M | 13.60M | 11.15M | 20.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
59.80M | 51.79M | 33.73M | 42.65M | 78.61M | 24.23M | Total Assets |
726.67M | 707.92M | 585.72M | 547.16M | 457.97M | 331.05M | Total Debt |
160.73M | 129.19M | 74.76M | 26.54M | 17.48M | 19.59M | Net Debt |
100.94M | 77.41M | 41.02M | -16.11M | -61.13M | -4.64M | Total Liabilities |
401.04M | 381.17M | 257.35M | 241.98M | 165.61M | 130.65M | Stockholders Equity |
325.64M | 326.75M | 328.37M | 305.19M | 292.36M | 200.41M |
Cash Flow | Free Cash Flow | ||||
63.53M | 75.42M | 48.34M | 35.82M | 38.69M | -8.55M | Operating Cash Flow |
74.06M | 87.22M | 56.77M | 43.14M | 46.54M | -2.75M | Investing Cash Flow |
-62.16M | -99.67M | -79.62M | -72.89M | -56.61M | -35.19M | Financing Cash Flow |
-3.13M | 30.50M | 13.94M | -6.21M | 64.44M | 45.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | C$112.83M | 15.66 | 21.19% | 1.23% | -5.30% | ― | |
77 Outperform | C$1.76B | 9.91 | 9.65% | 23.14% | -2.58% | 100.21% | |
74 Outperform | C$371.00M | 20.71 | 9.69% | 3.40% | 16.35% | 3.98% | |
72 Outperform | C$545.51M | 17.35 | 15.03% | 4.00% | -10.24% | -23.79% | |
71 Outperform | C$776.60M | 19.49 | 7.93% | ― | 1.49% | 152.09% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 3.67% | 4.15% | -12.21% | |
58 Neutral | C$508.00M | 12,072.97 | 0.01% | 2.51% | 3.03% | -99.78% |
Calian Group reported its second-quarter results, highlighting a 13% growth in its defense solutions, driven by increased global security needs. However, the company faced challenges in its ITCS segment due to slower customer demand and strategic investments for long-term growth. Revenue decreased by 4% to $194 million, while adjusted EBITDA fell by 36% to $17 million. Despite withdrawing its guidance due to economic and geopolitical uncertainties, Calian remains optimistic about future growth, supported by strong signings, a robust M&A pipeline, and the recent acquisition of Advanced Medical Solutions.
The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$80.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.
Calian Group Ltd. has acquired Advanced Medical Solutions (AMS), a leading provider of remote and emergency healthcare services in Northern Canada. This strategic acquisition aims to enhance healthcare access and outcomes in Canada’s northern regions by combining the expertise and resources of both companies. The partnership will support the expansion of healthcare services in underserved communities, aligning with national priorities and upcoming federal investments in the Arctic region. AMS will operate under Calian during the transition, with a focus on maintaining service continuity and strengthening community partnerships.
The most recent analyst rating on (TSE:CGY) stock is a Buy with a C$80.00 price target. To see the full list of analyst forecasts on Calian Group stock, see the TSE:CGY Stock Forecast page.
Calian Group Ltd. is addressing the increasing demand for psychological services among Canada’s public safety agencies by expanding its mental health support offerings. The company has experienced significant growth, with a 25% increase in fiscal year 2024 and the addition of 17 new and renewed contracts in the first half of FY25. Calian’s services, which include pre-employment assessments and wellness programs, aim to build resilient public safety workforces and reduce mental health challenges. The company’s efforts are crucial in enhancing team performance and community safety, as public safety personnel face high-stress situations that increase their risk of mental health disorders.
Calian Group Ltd. announced it will hold a conference call on May 14, 2025, to discuss its second-quarter results for the fiscal year 2025, which will be released earlier that day. This announcement underscores Calian’s commitment to transparency and engagement with its stakeholders, as it continues to navigate the competitive landscape in its diverse sectors.
Calian Group Ltd. has announced the appointment of Eric Demirian to its Board of Directors, expanding the board to ten members. Demirian brings extensive financial expertise and experience from his roles in various public and private companies, making him a strategic asset for Calian as it continues its growth journey. His appointment is expected to enhance Calian’s ability to navigate complex financial landscapes and drive long-term value for shareholders.
Calian Group Ltd. announced plans to increase its share repurchases through block trades, aiming to buy back approximately 250,000 shares worth around $10 million. This decision comes as the company experiences a share price at five-year lows despite consecutive record years of revenue and adjusted EBITDA. Calian’s CEO, Kevin Ford, emphasized the company’s growth potential and the market’s underestimation of its opportunities in defense, space, and healthcare sectors. The move is part of Calian’s strategy to enhance shareholder value and align with its M&A agenda, which remains a top priority for capital allocation.